E. Sparrelid

RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1

Per Ljungman, J Aschan, Ilona Lewensohn‐Fuchs et al. · Transplantation · 1998 · 177 citations

TEN YEARS' EXPERIENCE OF BONE MARROW TRANSPLANTATION FOR GAUCHER DISEASE

Olle Ringdén, C. G. Groth, Anders Erikson et al. · Transplantation · 1995 · 154 citations

Transplantation, Marrow Transplantation, Autoimmune Disease +13

Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations

Ola Blennow, Per Ljungman, E. Sparrelid et al. · Transplant Infectious Disease · 2013 · 133 citations

Intravenous immune globulin affects cytokine production in T lymphocytes and monocytesjmacrophages

Jan Andersson, U Skansén-Saphir, E. Sparrelid · Clinical & Experimental Immunology · 1996 · 133 citations

Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections

E. Sparrelid, Per Ljungman, E Ekelöf-Andström et al. · Bone Marrow Transplantation · 1997 · 126 citations

Transplantation, Viral Persistence, Ribavirin Therapy +4